• Je něco špatně v tomto záznamu ?

The crucial role of emilin 1 gene expression during progression of tumor growth

M. Rabajdova, P. Urban, I. Spakova, L. Saksun, R. Dudic, A. Ostro, M. Caprnda, P. Kruzliak, M. Adamek, M. Marekova,

. 2016 ; 142 (11) : 2397-402. [pub] 20160831

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013561
E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2003-04-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 1997-01-01 do Před 1 rokem
Springer Nature OA/Free Journals od 1904-02-01

BACKGROUND: This study describes the effect of rapid tumor growth of patients suffering from various grades of malignant ductal breast carcinoma associated with the gene expression of ECM protein emilin 1, in correlation with the number of gene copies of emilin 1 and degradation of tumor tissue proteins. METHODS: A total of 40 examined patients participated in the experiment (controls, n = 10, grades GI-GIII, each n = 10). After isolation of total mRNA, transcription of mRNA into the cDNA was performed. Quantification of gene expression changes was detected by the real-time PCR method. Analysis at the protein level was performed via Western blot method. RESULTS: During the detection of changes at the mRNA level, a significantly decreased level of emilin 1 in tumor tissues with grade II (about 54 ± 8 % lower than control) was identified. Protein-level analysis indicated an increased level of emilin 1 in tumors with grade I in comparison with control samples (about 10 ± 3 %). CONCLUSION: Obtained results demonstrated that the suppressive role of emilin 1 is related to the grade of growing breast tumors, and associated with increased hypoxia in the tumor microenvironment followed by elevated unfolding and degradation of tissue proteins.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013561
003      
CZ-PrNML
005      
20170426115454.0
007      
ta
008      
170413s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00432-016-2226-0 $2 doi
035    __
$a (PubMed)27581738
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Rabajdova, Miroslava $u Department of Medical and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef Safarik University, Trieda SNP 1, 040 11, Kosice, Slovakia.
245    14
$a The crucial role of emilin 1 gene expression during progression of tumor growth / $c M. Rabajdova, P. Urban, I. Spakova, L. Saksun, R. Dudic, A. Ostro, M. Caprnda, P. Kruzliak, M. Adamek, M. Marekova,
520    9_
$a BACKGROUND: This study describes the effect of rapid tumor growth of patients suffering from various grades of malignant ductal breast carcinoma associated with the gene expression of ECM protein emilin 1, in correlation with the number of gene copies of emilin 1 and degradation of tumor tissue proteins. METHODS: A total of 40 examined patients participated in the experiment (controls, n = 10, grades GI-GIII, each n = 10). After isolation of total mRNA, transcription of mRNA into the cDNA was performed. Quantification of gene expression changes was detected by the real-time PCR method. Analysis at the protein level was performed via Western blot method. RESULTS: During the detection of changes at the mRNA level, a significantly decreased level of emilin 1 in tumor tissues with grade II (about 54 ± 8 % lower than control) was identified. Protein-level analysis indicated an increased level of emilin 1 in tumors with grade I in comparison with control samples (about 10 ± 3 %). CONCLUSION: Obtained results demonstrated that the suppressive role of emilin 1 is related to the grade of growing breast tumors, and associated with increased hypoxia in the tumor microenvironment followed by elevated unfolding and degradation of tissue proteins.
650    _2
$a western blotting $7 D015153
650    _2
$a nádory prsu $x genetika $x metabolismus $7 D001943
650    _2
$a duktální karcinom prsu $x genetika $x metabolismus $7 D018270
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a komplementární DNA $x genetika $x metabolismus $7 D018076
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genová dávka $7 D018628
650    _2
$a exprese genu $7 D015870
650    _2
$a lidé $7 D006801
650    _2
$a membránové glykoproteiny $x biosyntéza $x genetika $7 D008562
650    _2
$a stupeň nádoru $7 D060787
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
655    _2
$a časopisecké články $7 D016428
700    1_
$a Urban, Peter $u Department of Medical and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef Safarik University, Trieda SNP 1, 040 11, Kosice, Slovakia.
700    1_
$a Spakova, Ivana $u Department of Medical and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef Safarik University, Trieda SNP 1, 040 11, Kosice, Slovakia.
700    1_
$a Saksun, Ladislav $u Department of Pathology, Saca Hospital, Kosice, Slovakia.
700    1_
$a Dudic, Rastislav $u Department of Gynecology and Obstetrics, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
700    1_
$a Ostro, Alexander $u Department of Gynecology and Obstetrics, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
700    1_
$a Caprnda, Martin $u 2nd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
700    1_
$a Kruzliak, Peter $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr. 1946/1, 612 42, Brno, Czech Republic. kruzliakpeter@gmail.com. 2nd Department of Surgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic. kruzliakpeter@gmail.com.
700    1_
$a Adamek, Mariusz $u Department of Thoracic Surgery, Medical University of Silesia, Zabrze, Poland. $7 gn_A_00001291
700    1_
$a Marekova, Maria $u Department of Medical and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef Safarik University, Trieda SNP 1, 040 11, Kosice, Slovakia. maria.marekova@upjs.sk.
773    0_
$w MED00009972 $t Journal of cancer research and clinical oncology $x 1432-1335 $g Roč. 142, č. 11 (2016), s. 2397-402
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27581738 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170426115813 $b ABA008
999    __
$a ok $b bmc $g 1200026 $s 974339
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 142 $c 11 $d 2397-402 $e 20160831 $i 1432-1335 $m Journal of cancer research and clinical oncology $n J Cancer Res Clin Oncol $x MED00009972
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...